Publication | Closed Access

Isoliquiritigenin protects against blood‑brain barrier damage and inhibits the secretion of pro-inflammatory cytokines in mice after traumatic brain injury

InflammationNeuroinflammationTraumatic Brain InjuryBlood‑brain Barrier DamageCytokineHealth SciencesBlood–brain BarrierPro-inflammatory CytokinesMedicinePhysiologyImmunologyBrain-immune InteractionBrain InjuryNeuroprotectionPharmacologyNeuroimmunologyOxidative StressTissue Injury